• Explore /
  • Poster
  • / A randomized phase II trial of second-line treatment for advanced soft tissue sarcoma comparing trabectedin, eribulin and pazopanib (2ND-STEP, JCOG1802).

A randomized phase II trial of second-line treatment for advanced soft tissue sarcoma comparing trabectedin, eribulin and pazopanib (2ND-STEP, JCOG1802).

Abstract Video & Slides Poster

Authors

null

Makoto Endo

Kyushu University Hospital, Fukuoka, Japan

Makoto Endo , Kazuhiro Tanaka , Yoshihiro Matsumoto , Hiroaki Hiraga , Shintaro Iwata , Satoshi Tsukushi , Munenori Watanuki , Toru Akiyama , Tsukasa Yonemoto , Robert Nakayama , Keisuke Ae , Hiroyuki Kawashima , Hiroyuki Tsuchiya , Hirohisa Katagiri , Akihito Nagano , Satoshi Takenaka , Tomoko Kataoka , Ryunosuke Machida , Haruhiko Fukuda , Toshifumi Ozaki

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Sarcoma

Track

Sarcoma

Sub Track

Soft Tissue Tumors

Clinical Trial Registration Number

jRCTs031190152

Citation

J Clin Oncol 39, 2021 (suppl 15; abstr TPS11580)

DOI

10.1200/JCO.2021.39.15_suppl.TPS11580

Abstract #

TPS11580

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

First Author: Andrew Eugene Hendifar

First Author: Richard Hong Hui Quek

First Author: Kristine Peregrino Lacuna

First Author: Erlinda Maria Gordon